Study Group: Nicorandil for Angina Experts: Cardiologists (US)(?)
Council Members in this Study Group: 10
Request a survey with this Study Group
Leading Experts in this Study Group
Director of Cardiac Catheterization Lab
Wadsworth VA Medical Center
Ramin Ebrahimi, MD, is Associate Clinical Professor at the University of California in Los Angeles. He is also Director of the Cardiac Catheterization Laboratory and Assistant Director of Nuclear Cardiology at the Wadsworth VA Medical Center. Dr. Ebrahimi’s clinical and research interests focus on interventional...
Bernard Chaitman, MDProfessor and Director
SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE
Bernard Chaitman, MD, is Professor of Internal Medicine and Director of Cardiovascular Research at the St. Louis University School of Medicine in Missouri. He is also the Director of the Core ECG Laboratory. Dr. Chaitman has research interests in anti-anginal drug therapies, including Ranolazine, Nicorandil,...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
I am a heavy user of ARB's and Tekturna. This article does not really show anything of significance. Most practicing physicians have seen much better results and much better tolerability with ARB's than diuretics. I do not think this is going to change prescribing habits of anyone. ...
It is well known that the addition of thiazide diuretic to ACEI or ARB treatment adds about 10 mm Hg reduction on top of the 10 mm Hg reduction provided by the ACEI or ARB agent. It is expected that blocking renin in the renin angiotensin system with Tekturna would provide a similar result.
Questions about bleeding, proper dose and appropriate patient subsets will limit use
TRITON-TIMI 38 study of 13,608 patients with ACS compared prasugrel against clopidogrel, combined with aspirin. Prasugrel reduced the combined rate of CV death, MI or stroke (12.1% for clopidogrel vs. 9.9% for prasugrel). The benefit came at a cost of increased serious bleeding (1.4%, vs....
The impact on Vytorin and zetia sales will be modest reduction after the release of ENHANCE data
Physicians have several possible conclusions that can be taken; These include: - the trial is flawed - the selection of patients with much less CIMT than previous trials such as ASAP and ARBITER flaws the study - the failure to meet the trial endpoint is only a surrogate and clinical trial data...
This is great news for Canada. This is the first new drug approved for the treatment of acute heart failure since 1989, when milrinone was approved. Nesiritide was approved in the United States in 2001. Since then, it has proven to be of great benefit in patients with acute heart failure,...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Government/Military Hospital or Clinic
- Staffing and Recruiting Services - Retained
Most Common Job Types:
- Physician - Attending Physician
- Owner
- President
- Physician - Division Head
- Physician - Director